Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages

International Journal of Antimicrobial Agents

Volumn 32, Issue 1, 2008, Pages 40-45

  Khan, Arshad ^a   Sarkar, Sampa ^a   Sarkar, Dhiman ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

2 Nitroimidazole; Antimycobacterial agents; Nitroimidazoles; THP 1 macrophage; Tuberculosis

Indexed keywords

2 NITROIMIDAZOLE; BCG VACCINE; FURALTADONE; NITROFURANTOIN;

ARTICLE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; CELL LINE; COLONY COUNT, MICROBIAL; CULTURE MEDIA; ESCHERICHIA COLI; HUMANS; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NITROIMIDAZOLES; TIME FACTORS;

EID: 44949242900     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.02.022     Document Type: Article

References (21)

1. World Health, Organization, Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376 Geneva, Switzerland: WHO; 2007.
2. Raviglione M.C., Snider D.E., and Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273 (1995) 220-226
3. Helen P. Drug giant to offer new, cut-price tuberculosis treatment. Lancet Infect Dis 5 (2005) 744
4. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 2. Prevalence and trends. Geneva, Switzerland: WHO; 2000. http://www.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=93&codcch=2117 [accessed 20 March 2008].
5. Schluger N.W. The impact of drug resistance on the global tuberculosis epidemic. Int J Tuberc Lung Dis 4 Suppl. 1 (2000) S71-S75
6. Barry C.E., Boshoff H.I.M., and Dowd C.S. Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis. Curr Pharm Des 10 (2004) 3239-3262
7. Wayne L.G., and Sramek H.A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob Agents Chemother 38 (1994) 2054-2058
8. Murugasu-Oei B., and Dick T. Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG. J Antimicrob Chemother 46 (2000) 917-919
9. Stover C.K., Warrener P., VanDevanter D.R., Sherman D.R., Arain T.M., Langhorne M.H., et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405 (2000) 962-966
10. Ashtekar D.R., Costa-Perira R., Nagrajan K., Vishvanathan N., Bhatt A.D., and Rittel W. In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis. Antimicrob Agents Chemother 37 (1993) 183-186
11. Smith M.A., and Edwards D.I. Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs. J Antimicrob Chemother 6 (1995) 751-764
12. Grunberg E., Beskid G., Cleeland R., DeLorenzo W.F., Titsworth E., Scholer H.J., et al. Antiprotozoan and antibacterial activity of 2-nitroimidazole derivatives. Antimicrob Agents Chemother 7 (1967) 513-519
13. Roe F.J. Safety of nitroimidazoles. Scand J Infect Dis Suppl 46 (1985) 72-81
14. Khan A., and Sarkar D. Identification of a respiratory-type nitrate reductase and its role for survival of Mycobacterium smegmatis in Wayne model. Microb Pathog 41 (2006) 90-95
15. Wayne L.G., and Hayes L.G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64 (1996) 2062-2069
16. Sun Z., and Zhang Y. Antituberculosis activities of certain antifungal and antihelmintic drugs. Tuber Lung Dis 79 (1999) 319-320
17. Wallace Jr. R.J., Nash D.R., Steele L.C., and Steingrube V. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol 6 (1986) 976-981
18. Cavalleri B., Ballotta R., Arioli V., and Lancini G. New 5-substituted 1-alkyl-2-nitroimidazoles. J Med Chem 16 (1973) 557-560
19. Cavalleri B., Volpe G., and Arioli V. Synthesis and biological activity of some vinyl-substituted 2-nitroimidazoles. J Med Chem 20 (1977) 656-660
20. Lenaerts A.J., Gruppo V., Marietta K.S., Johnson C.M., Driscoll D.K., Tompkins N.M., et al. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob Agents Chemother 49 (2005) 2294-2301
21. Tyagi S., Nuermberger E., Yoshimatsu T., Williams K., Rosenthal I., Lounis N., et al. Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis. Antimicrob Agents Chemother 49 (2005) 2289-2293